These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 20083693

  • 1. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study.
    Yan AC, Honig PJ, Ming ME, Weber J, Shah KN.
    Arch Dermatol; 2010 Jan; 146(1):57-62. PubMed ID: 20083693
    [Abstract] [Full Text] [Related]

  • 2. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba.
    Fujita WH, McCormick CL, Parneix-Spake A.
    Int J Dermatol; 2007 Jul; 46(7):700-5. PubMed ID: 17614797
    [Abstract] [Full Text] [Related]

  • 6. Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a > 2000 patient study.
    Ring J, Abraham A, de Cuyper C, Kim K, Langeland T, Parra V, Pigatto P, Reunala T, Szczepanski R, Möhrenschlager M, Bräutigam M, Rossi AB, Meents-Kopecky E, Schneider D.
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):195-203. PubMed ID: 18211413
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP, Whalley D, de Prost Y, Staab D, Huels J, Paul CF, van Assche D.
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [Abstract] [Full Text] [Related]

  • 11. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women.
    Oskay T, Sezer HK, Genç C, Kutluay L.
    Int J Dermatol; 2007 May; 46(5):527-32. PubMed ID: 17472689
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.
    Dawid M, Veensalu M, Grassberger M, Wolff K.
    J Dtsch Dermatol Ges; 2006 Nov; 4(11):942-6. PubMed ID: 17081269
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
    Ho VC, Gupta A, Kaufmann R, Todd G, Vanaclocha F, Takaoka R, Fölster-Holst R, Potter P, Marshall K, Thurston M, Bush C, Cherill R.
    J Pediatr; 2003 Feb; 142(2):155-62. PubMed ID: 12584537
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
    Leung DY, Hanifin JM, Pariser DM, Barber KA, Langley RG, Schlievert PM, Abrams B, Hultsch T.
    Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.